3-Methyl-4-nitroanisole

Catalog No.: 
ACGXTR921
CAS No.: 
5367-32-8
Molecular Formula: 
C8H9NO3
Molecular Weight: 
167.16
3-Methyl-4-nitroanisole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$56.00In stockInquiry
500g97%$222.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methyl-4-nitroanisole
IUPAC Name4-methoxy-2-methyl-1-nitrobenzene
MDL No.MFCD00007167
Molecular FormulaC8H9NO3
Molecular Weight167.16
SMILESCOC1=CC=C([N+]([O-])=O)C(C)=C1
InChI KeyRTZOGYCMIMOVHU-UHFFFAOYSA-N
Synonym3-Methyl-4-nitroanisole | AM62020 | CS-W017846 | EN300-102351 | AE-562/43286417 | M1369 | W-105714 | 2-Nitro-5-methoxytoluene | Nitrobenzene, 4-methoxy-6-methyl- | Z208835124 | Benzene, 4-methoxy-2-methyl-1-nitro- | 3-Methyl-4-nitrophenol methyl ether | D
CAS No.5367-32-8
PubChem CID79330

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACGXTR921 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACTEPI768 route compound structure diagram
    ACTEPI768446-33-3In Stock
  4. Then
  5. ACGXTR921 route product structure diagram
    ACGXTR9215367-32-8In Stock
Inquiry

2. ACGXTR921 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGXTR921 route product structure diagram
    ACGXTR9215367-32-8In Stock
Inquiry

3. ACGXTR921 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGXTR921 route product structure diagram
    ACGXTR9215367-32-8In Stock
Inquiry

Comments (0)